Acceleron Pharma To Present At Upcoming Investor Conferences In September
8/27/2014 8:57:23 AM
Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced that over the next two weeks, it will participate in several investor conferences.
Help employers find you! Check out all the jobs and post your resume.
comments powered by